Matthew Linnik Ph.D., Executive Vice President of Research, will present these results today at the 26th International Stroke Conference, sponsored by the American Stroke Association, a division of the American Heart Association, in Ft. The conference will be held at the Waldorf Astoria Hotel in New York City. Using small molecules to regulate the extent to which a gene is activated, scientists can identify the physiologic or pathologic consequences of turning a given gene on or off. This technology has direct applications to interpreting the mass of information generated by the human genome project - identifying the specific functions and controls of each of the approximately 30,000 genes in the human genome and relating them to human biology and disease. Such Information is neither an offer to sell nor a solicitation to buy the securities of any company.
Additional information is available upon request.
Information in this publication has been obtained from sources believed to be reliable, but the accuracy, completeness and interpretation are not guaranteed. Opinions expressed are subject to change without notice. BioSpace, and BioSpace's employees and officers, as well as Wayne Hummer Investments LLC, and Wayne Hummer Investments LLC 's employees and officers, in no way accept responsibility for any of the Newsletter's content. The Information is supplied on the condition that the reader or any other person receiving the Information will make his or her own determination as to its suitability for any purpose prior to any use of the Information. Also BioSpace, Inc. and Wayne Hummer Investments LLC may, from time to time solicit business from any company mentioned in this report.